At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
NeuroPace RNS® System Deep Brain Stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Scheduled and Responsive Brain Stimulation for the Treatment of Tourette Syndrome
In Brief
A clinical study evaluating NeuroPace RNS® System Deep Brain Stimulator for Tourette Syndrome. Completed, enrolled 5 participants across 1 site.
Detailed Summary
The purpose of this trial is to determine whether a particular type of Deep Brain Stimulation (DBS), scheduled Deep Brain stimulation (SBS), is an effective and safe treatment for Tourettte syndrome (TS). The trial will also examine the brain activity associated with TS and tics and explore the possibility of responsive brain stimulation (RBS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedApr 2011
Primary CompletionNov 2011
Study CompletionApr 2017
TodayJul 2026
First PostedApr 5, 2011
Enrollment StartSep 1, 2009
Primary CompletionNov 1, 2011
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 15.2 years ago
Interventions
NeuroPace RNS® System Deep Brain Stimulatordevice
Utilizes a signal that the device detects and will respond to with an electrical pre-defined pulse if the signal is encountered.